BRIEF — UCB Annouces FDA Approval For Zilbrysq Autoinjector Self — Administration For Adults Living With Generalized Myasthenia Gravis

Oct 16 (Reuters) — Ucb SA: Announces U.s. Fda Approval For Zilbrysq (Zilucoplan) Autoinjector Self-administration For Adults Living With Generalized Myasthenia Gravis Prior To Autoinjector's Approval, Zilbrysq Was Available As A Self-administered Prefilled Syringe (Pfs) Expects Autoinjector To Be Available Commercially In Q1 2027 Source text: nPLX4555H6 Further company coverage: UCB.BR (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;)